Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma

PURPOSE: The purpose of this study was to retrospectively analyze the safety and clinical efficacy of anlotinib combined with dose-dense temozolomide (TMZ) as the first-line therapy in the treatment of recurrent glioblastoma (rGBM). PATIENTS AND METHODS: We collected the clinical data of 20 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: She, Lei, Su, Lin, Shen, Liangfang, Liu, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330423/
https://www.ncbi.nlm.nih.gov/pubmed/34354945
http://dx.doi.org/10.3389/fonc.2021.687564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330423/
https://www.ncbi.nlm.nih.gov/pubmed/34354945
http://dx.doi.org/10.3389/fonc.2021.687564

Ejemplares similares